Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer

The HERO study compared how well relugolix and leuprolide worked in lowering blood testosterone to sustained castration levels in men with advanced prostate cancer. This is plain language summary provides an overview of this study.

Read the full article here.

Click here to read the original article on which this summary is based.

• androgen-deprivation therapy
• GnRH agonist
• GnRH antagonist
• leuprolide